Royal Bank of Canada’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-271
Closed 7921
2023
Q3
$0 Buy
271
+87
+47% +$82 ﹤0.01% 7987
2023
Q2
$0 Buy
+184
New +$291 ﹤0.01% 8014
2022
Q4
Sell
-4
Closed 8219
2022
Q3
$0 Buy
+4
New +$202 ﹤0.01% 8278
2021
Q3
Sell
-16
Closed -$6K 8195
2021
Q2
$6K Sell
16
-10
-38% -$3.27K ﹤0.01% 7055
2021
Q1
$10K Buy
26
+4
+18% +$1.73K ﹤0.01% 6835
2020
Q4
$9K Buy
+22
New +$9.52K ﹤0.01% 6459
2018
Q4
Hold
0
7399
2018
Q3
Hold
0
7128
2018
Q1
Hold
0
7057
2017
Q4
Hold
0
7133
2017
Q3
Hold
0
7158
2017
Q2
Hold
0
6935
2017
Q1
Hold
0
6945

Other funds holding CFRX

Royal Bank of Canada's CFRX Position: Q4 2023 in Review

Royal Bank of Canada sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 271 shares.

Royal Bank of Canada first reported a position in CFRX in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2021. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

  • Royal Bank of Canada reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 271 ContraFect Corporation shares in Q4 2023.
  • Royal Bank of Canada first reported a position in ContraFect Corporation in Q4 2020 and held it in 6 quarters.
  • Royal Bank of Canada's ContraFect Corporation position peaked at $10K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.